The Center for Human Development confirmed a new case of pertussis, commonly known as whooping cough, in Union County. The announcement underscores the contagious nature of this bacteria-caused respiratory infection and highlights the need for public awareness.

Northern California is seeing an unusual rise in rotavirus infections this season, marked by severe diarrhea and vomiting. Health experts note that children between 3 months and 3 years old are the most affected by this “late-spring surge.”

A new report highlights more than 75 drugs under consideration for Duchenne muscular dystrophy, promising significant progress in patient care. The analysis explores clinical strategies, upcoming therapies, and commercial prospects, signaling a major shift in the DMD landscape.

Two of Climb Bio’s most promising therapies—CLYM116 and budoprutug—will be in the spotlight at the European Renal Association Congress 2026. The company is sharing early safety data and a Phase 2 trial update in Glasgow, Scotland, detailing its mission to advance treatment options for immune-mediated kidney diseases.

The World Health Organization warns that Ebola in the Democratic Republic of Congo is spreading faster than efforts to contain it. Countries bordering the DRC face high risk, spurring the WHO to intensify its operations. Still, officials caution that the epidemic may be growing beyond their current capability to control.

This article presents nine foundational steps designed to support heart-healthy living over the long term. While the full details remain unavailable, it offers a foundation for readers seeking strategies to maintain cardiovascular wellness.

Health care leaders in southern Illinois are urging families to schedule back-to-school physicals and vaccinations well before the new academic year begins. By acting now, parents can manage requirements, avoid a late-season rush, and keep their children’s health on track.

A newly approved weight-loss drug, Foundayo (orforglipron), has arrived months ahead of schedule after gaining FDA clearance in just 50 days. The swift approval signals a growing momentum in the development of anti-obesity treatments.

Esperion Therapeutics has completed its acquisition of Corstasis Therapeutics, bringing the FDA-approved Enbumyst nasal spray into its cardiovascular portfolio. This first-in-class nasal spray loop diuretic helps manage fluid retention for congestive heart failure, marking a new step in Esperion’s plan to address the growing global burden of cardiometabolic disease. Executives anticipate that Enbumyst will bolster the company’s commercial capabilities and revenue growth.

Neutrolis, Inc. has released positive results from the Phase 1a portion of its LIBERATE-I trial, spotlighting NTR-1011’s potential in dismantling harmful Neutrophil Extracellular Traps (NETs). This first-in-class DNASE1L3 fusion protein aims to address chronic inflammatory pathways without compromising the immune system.

Heart health doesn’t exist in isolation. According to available information, medical experts stress that closely monitoring blood sugar and kidney function can play a critical role in comprehensive cardiovascular care.

Chronic Fatigue Syndrome (CFS) continues to confound medical experts and patients alike, affecting millions of Americans. New evidence suggests that nearly half of CFS cases may be tied to tick-borne infections, sparking urgent questions about diagnosis and accurate case counts.

Brii Biosciences announced full-year 2025 results, emphasizing progress in its hepatitis B treatments and a robust cash position of US$276.1 million. The Company’s Phase 2b HBV trials, ENRICH and ENHANCE, have fully enrolled and are poised for key data readouts in the second half of 2026.

University of Mississippi students have a unique chance to help save an 11-year-old Mississippi girl’s life this week. By joining the national bone marrow donor registry, they could offer hope and potentially provide a life-saving match.

Research suggests that the time of day when certain treatments—such as cancer therapies or vaccines—are given can influence their effectiveness. Scientists are examining how the body’s internal clock, or circadian rhythm, might be the key to unlocking better patient outcomes.

IgA nephropathy is a silent attack on the kidneys that often goes unnoticed. With new treatments on the horizon, early diagnosis could save countless lives by preventing further damage and prolonging kidney function.

A new generation of medications first developed for diabetes is now offering hope for chronic kidney disease patients. Three types of these drugs, including one famously known as Ozempic, are transforming the outlook for individuals who have long waited for more effective treatment options.

Cholesterol is recognized as a crucial factor for heart wellness. Although the full story remains behind a paywall, the overarching message points toward the importance of staying informed about this vital element of cardiovascular health.

Mdxhealth has unveiled new findings from Oxford’s ProMPT Study, which show that the Genomic Prostate Score (GPS) test can predict adverse outcomes for prostate cancer patients. Presented at EAU 2026, this research highlights the test’s broad relevance across multiple treatment approaches.

A stray cat bit a Lawton resident and was later confirmed to have rabies, according to the Oklahoma State Department of Health. The incident highlights the ongoing need for vigilance regarding the virus.

A far-reaching survey from the Bladder Cancer Advocacy Network (BCAN) reveals that countless patients still face late diagnoses and limited support despite medical advancements. More than 1,100 respondents from nearly every state report gaps not only in financial protection but also in mental health services.